Abstract
Using a newly developed sensitive gas chromatograph-mass spectrometer assay for benzquinamide, pharmacokinetics have been determined in man follovnng the administration of intramuscular, oral, and rectal suppository doses. Drug is absorbed most rapidly from the intramuscular dose and least rapidly from suppositories. The mean apparent elimination half-life is 1.0–1.6 hr from all formulations. Benzquinamide is 33–39% bioavailable from the capsule and suppository formulations, relative to the intramuscular formulation. A high correlation between capsule and suppository bioavailabilities suggests that first-pass metabolism may account for at least part of the incomplete availability.
Similar content being viewed by others
References
N. E. Pitts. A clinical pharmacological evaluation of benzquinamide, a new anti-emetic agent.Curr. Ther. Res. 11:325–337 (1969).
R. L. Klein, C. L. Graves, Y. I. Kim, and R. Blatnick. Inhibition of apomorphine-induced vomiting by benzquinamide.clin. Pharmacol. Ther. 11:530–537 (1970).
J. Medoff. A double-blind evaluation of the anti-emetic efficacy of benzquinamide, prochlorperazine and trimethobenzamide in office practice.Curr. Ther. Res. 12: 706–710 (1970).
H. Lutz and H. Immich. Anti-emetic effect of benzquinamide in postoperative vomiting.Curr. Ther. Res. 14:178–184 (1972).
E. H. Wiseman, E. C. Schreiber, and R. Pinson, Jr. The distribution, excretion and metabolism of benzquinamide.Biochem. Pharmacol. 13:1421–1435 (1964).
B. K. Koe and R. Pinson, Jr. Isolation and characterization of urinary metabolites of benzquinamide and benzquinamide alcohol.J. Med. Chem. 7:635–640 (1964).
B. Cahn, L. S. Brahen, E. H. Wiseman, and R. Pinson, Jr. Urinary excretion of benzquinamide in humans.Curr. Ther. Res. 5:301–304 (1963).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hobbs, D.C., Connolly, A.G. Pharmacokinetics of benzquinamide in man. Journal of Pharmacokinetics and Biopharmaceutics 6, 477–485 (1978). https://doi.org/10.1007/BF01062104
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01062104